Figures and Tables

From the following article:

Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation

Nicholas W Choong, Sascha Dietrich, Tanguy Y Seiwert, Maria S Tretiakova, Vidya Nallasura, Gareth C Davies, Stanley Lipkowitz, Aliya N Husain, Ravi Salgia and Patrick C Ma

Nature Clinical Practice Oncology (2006) 3, 50-57
doi:10.1038/ncponc0400

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Lung adenocarcinoma tumor cells and EGFR somatic mutations

Full size and legend (63K)Download PowerPoint slide (271K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Response to gefitinib in the primary tumor and thoracic involved lymph nodes

Full size and legend (92K)Download PowerPoint slide (284K)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

Response to gefitinib in extensive leptomeningeal carcinomatosis

Full size and legend (100K)Download PowerPoint slide (278K)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

EGFR mutations and differential effects on the sensitivity of the receptor towards inhibition by erlotinib and gefitinib

Full size and legend (80K)Download PowerPoint slide (289K)
Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 5

Summary of EGFR mutations and their effects on sensitivity and resistance towards inhibition by EGFR small molecule inhibitors

Full size and legend (58K)Download PowerPoint slide (255K)
Table 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 1

Laboratory analysis of the patient's cerebrospinal fluid

Full size and legend Download PowerPoint slide (254K)
BACK TO ARTICLE